. . . . . . . . . "\"GVOKE is contraindicated in patients with: Pheochromocytoma [ see Warnings and Precautions ( 5.1 Insulinoma [ see Warnings and Precautions ( 5.2 Known hypersensitivity to glucagon or to any of the excipients in GVOKE. Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension [ see Warnings and Precautions ( 5.3 Pheochromocytoma ( 4 Insulinoma ( 4 Known hypersensitivity to glucagon or to any of the excipients ( 4\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "PKNiZyPm62x1o+yw2vKVT64+P/Iyaca1wAuMpZhrDNHx8HtWSR5hpw7Z0EC6nX4RP2B10VnWwUri8AS+UoGw4w26/4XKVfyirbDWgY5a9uuiIcB5cglSmqWoEvORfNChSIFaKrhJbD/P6wv6WscsfEGvTYOOzyvS4tqOMcbex2k=" . . "2021-08-25T13:32:36.032+02:00"^^ . . . . .